rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-2-27
|
pubmed:abstractText |
We evaluated the response to infliximab in pediatric patients with ulcerative colitis (UC) and their long-term follow-up. We expanded our previous study of 14 patients and furthermore evaluated the success of weaning patients from infliximab.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1536-4801
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
312-7
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:17325550-Adolescent,
pubmed-meshheading:17325550-Adult,
pubmed-meshheading:17325550-Anti-Inflammatory Agents,
pubmed-meshheading:17325550-Antibodies, Monoclonal,
pubmed-meshheading:17325550-Child,
pubmed-meshheading:17325550-Child, Preschool,
pubmed-meshheading:17325550-Colitis, Ulcerative,
pubmed-meshheading:17325550-Female,
pubmed-meshheading:17325550-Follow-Up Studies,
pubmed-meshheading:17325550-Humans,
pubmed-meshheading:17325550-Immunologic Factors,
pubmed-meshheading:17325550-Male,
pubmed-meshheading:17325550-Time Factors
|
pubmed:year |
2007
|
pubmed:articleTitle |
Short- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis.
|
pubmed:affiliation |
Department of Pediatric Gastroenterology & Nutrition, Massachusetts General Hospital for Children, Boston 02114, USA. gfanjiang@partners.org
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|